Similar articles

• [Sclerosing cholangitis, ataxia-telangiectasia and Hodgkin's disease].

  Tallón García M, Cobelas Cobelas M, Fernández Sanmartín M, Cabo Pérez M, García Burriel I, Fiaño Valverde C. Tallón García M, et al. An Pediatr (Barc). 2011 Aug;75(2):141-3. doi: 10.1016/j.anpedi.2011.02.011. Epub 2011 Apr 8. An Pediatr (Barc). 2011. PMID: 21482209 Spanish. No abstract available.
• [Oncologic complications and cytogenetic features of ataxia telangiectasia].

  Deschildre A, Vallee L, Croquette MF, Nelken B, Nuyts JP. Deschildre A, et al. Arch Fr Pediatr. 1990 Mar;47(3):203-5. Arch Fr Pediatr. 1990. PMID: 2344249 French.
• [Proceedings: Neoplastic complications of ataxia telangiectasia].

  Olive D, Gehin AM, Boilletot A, Gilgenkrantz S, Vigneron C, Gerbeaux J, Gall EL, Raffoux S, Neimann N. Olive D, et al. Arch Fr Pediatr. 1975 Mar;32(3):292. Arch Fr Pediatr. 1975. PMID: 1063556 French. No abstract available.
• Hodgkin disease in ataxia-telangiectasia patients with poor outcomes.

  Sandoval C, Swift M. Sandoval C, et al. Med Pediatr Oncol. 2003 Mar;40(3):162-6. doi: 10.1002/mpo.10251. Med Pediatr Oncol. 2003. PMID: 12518345 Review.
• Chemo- and radiosensitivity testing in a patient with ataxia telangiectasia and Hodgkin disease.

  Tamminga RY, Dolsma WV, Leeuw JA, Kampinga HH. Tamminga RY, et al. Pediatr Hematol Oncol. 2002 Apr-May;19(3):163-71. doi: 10.1080/088800102753541314. Pediatr Hematol Oncol. 2002. PMID: 11936729 Review.